Sweden· SE-20141230000034
Rapibloc 10 mg/ml Koncentrat till injektionsvätska, lösning
A medicinal product containing landiolol hydrochloride, registered in Sweden by Amomed Pharma GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Landiolol Hydrochloride
- Manufacturer
- Amomed Pharma GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20141230000034
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Landiolol hydrochloride in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaRAPIBLOCAmomed Pharma GmbH, Vídeň
- Japanランジオロール塩酸塩小野薬品工業
- NetherlandsLandiolol Hydrochloride Orpha-Devel 300 mg poeder voor oplossing voor infusieOrpha Devel Handels-und Vertriebs GmbH
- United StatesRAPIBLYKAOP Orphan Pharmaceuticals GmbH
- FranceRAPIBLOC 20 mg/2 ml, solution à diluer injectableAMOMED PHARMA (AUTRICHE)
- BelgiumRunrapiq 300 mgOrpha-Devel Handels und Vertriebs
- IrelandRapibloc 300 mg powder for solution for infusionOrpha-Devel Handels und Vertriebs GmbH
- NorwayRaplocAmomed Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 25 EEA countries. Names it is sold under:
- Austria · Rapibloc
- Belgium · Runrapiq
- Bulgaria · Рапиблок
- Cyprus · Rapibloc
- Czechia · Rapibloc
- Germany · Rapibloc
- Denmark · Rapibloc
- Estonia · Raploc
- Spain · Rapibloc
- Finland · Rapibloc
- France · Rapibloc
- Greece · Rapibloc
- Croatia · Rapibloc
- Hungary · Rapibloc
- Ireland · Rapibloc
- Italy · Landiobloc
- Lithuania · Raploc
- Latvia · Raploc
- Netherlands · Landiolol Hydrochloride Orpha-Devel, Rapibloc
- Norway · Raploc
- Poland · Runrapiq
- Portugal · Rapibloc
- Romania · Rapibloc
- Slovenia · Rapibloc
- Slovakia · Rapibloc
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2b5a95bc-791b-4d39-9921-dd7ed27b47b9 GET /v1/drugs/2b5a95bc-791b-4d39-9921-dd7ed27b47b9?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"PL"
],
"se_npl_id": "20141230000034",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20141230000034",
"product_doc_link": "https://docetp.mpa.se/LMF/Rapibloc%20concentrate%20for%20solution%20for%20injection%20SmPC_09001bee807a6904.pdf"
}See everything about landiolol hydrochloride.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.